Clinical trial
Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney…
NCT00016042 · St. Luke's Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00016042 |
|---|---|
| Title | Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer |
| Official title | Interleukin 12-Primed Activated T Cells For Patients With Metastatic Renal Cell Carcinoma Or Colorectal Carcinoma (Phase I) |
| Lead sponsor | St. Luke's Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Kidney Cancer |
| Intervention type | Biological, Drug |
| Interventions | lymphokine-activated killer cells, recombinant interferon alfa, sargramostim, fluorouracil |
| Start date | Jan 1, 2001 |
| First posted | Apr 5, 2004 |
| Last update posted | Sep 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: